Terragen Holdings Ltd

Terragen Holdings operates with a market capitalization of $16.46 million and a price-to-book ratio of 2.51, indicating a premium to its book value. The company's liquidity position is characterized by a current ratio of 5.34, suggesting strong short-term liquidity, but its operating cash flow of -$3.03 million and free cash flow of -$4.15 million highlight ongoing cash burn. Profitability metrics show a return on equity of -56.69% and a return on assets of -45.88%, both significantly below industry norms. The company's operating income of -$4.60 million and net income of -$3.72 million reflect substantial losses, with a gross profit of $792,230 failing to offset operating expenses. Terragen's revenue is concentrated in two products, Mylo and Great Land Plus, with no disclosed geographic diversification beyond Australia and New Zealand. The company's total revenue of $1.62 million in the latest period suggests limited scale and exposure to regional market conditions. The company's growth trajectory is constrained by negative operating and free cash flows, with no disclosed revenue growth in the latest period. The outlook for the current fiscal year does not indicate a reversal of the negative trend, and the next fiscal year's direction remains uncertain without significant operational or strategic changes. Risk factors include a negative net cash position after subtracting total debt, with a debt-to-equity ratio of 0.11. The company's dilution risk is currently low, but the absence of positive cash flows and the need for capital could increase dilution pressure in the future. Recent events include the continued development of microbial technology for agricultural applications, with no significant new product launches or strategic acquisitions disclosed in the latest financial period. The company remains focused on its core products and research initiatives.